Chanda, Tirtha http://orcid.org/0009-0009-0649-9301
Hauser, Katja http://orcid.org/0000-0001-9390-3505
Hobelsberger, Sarah
Bucher, Tabea-Clara http://orcid.org/0000-0002-8157-5513
Garcia, Carina Nogueira http://orcid.org/0000-0001-9092-5952
Wies, Christoph http://orcid.org/0000-0001-7136-298X
Kittler, Harald http://orcid.org/0000-0002-0051-8016
Tschandl, Philipp http://orcid.org/0000-0003-0391-7810
Navarrete-Dechent, Cristian
Podlipnik, Sebastian http://orcid.org/0000-0003-4150-0522
Chousakos, Emmanouil http://orcid.org/0000-0002-8127-4761
Crnaric, Iva
Majstorovic, Jovana http://orcid.org/0009-0004-0980-7430
Alhajwan, Linda
Foreman, Tanya
Peternel, Sandra http://orcid.org/0000-0001-8590-0451
Sarap, Sergei
Özdemir, İrem http://orcid.org/0000-0001-9764-4678
Barnhill, Raymond L.
Llamas-Velasco, Mar
Poch, Gabriela
Korsing, Sören
Sondermann, Wiebke http://orcid.org/0000-0002-3684-3523
Gellrich, Frank Friedrich http://orcid.org/0000-0002-2164-4644
Heppt, Markus V.
Erdmann, Michael http://orcid.org/0000-0001-7136-6489
Haferkamp, Sebastian
Drexler, Konstantin
Goebeler, Matthias http://orcid.org/0000-0001-7095-9848
Schilling, Bastian http://orcid.org/0000-0001-8859-4103
Utikal, Jochen S. http://orcid.org/0000-0001-5316-0241
Ghoreschi, Kamran http://orcid.org/0000-0002-5526-7517
Fröhling, Stefan http://orcid.org/0000-0001-7907-4595
Krieghoff-Henning, Eva
,
Salava, Alexander
Thiem, Alexander
Dimitrios, Alexandris
Ammar, Amr Mohammad
Vučemilović, Ana Sanader
Yoshimura, Andrea Miyuki
Ilieva, Andzelka
Gesierich, Anja
Reimer-Taschenbrecker, Antonia
Kolios, Antonios G. A.
Kalva, Arturs
Ferhatosmanoğlu, Arzu
Beyens, Aude
Pföhler, Claudia
Erdil, Dilara Ilhan
Jovanovic, Dobrila
Racz, Emoke
Bechara, Falk G.
Vaccaro, Federico
Dimitriou, Florentia
Rasulova, Gunel
Cenk, Hulya
Yanatma, Irem
Kolm, Isabel
Hoorens, Isabelle
Sheshova, Iskra Petrovska
Jocic, Ivana
Knuever, Jana
Fleißner, Janik
Thamm, Janis Raphael
Dahlberg, Johan
Lluch-Galcerá, Juan José
Figueroa, Juan Sebastián Andreani
Holzgruber, Julia
Welzel, Julia
Damevska, Katerina
Mayer, Kristine Elisabeth
Maul, Lara Valeska
Garzona-Navas, Laura
Bley, Laura Isabell
Schmitt, Laurenz
Reipen, Lena
Shafik, Lidia
Petrovska, Lidija
Golle, Linda
Jopen, Luise
Gogilidze, Magda
Burg, Maria Rosa
Morales-Sánchez, Martha Alejandra
Sławińska, Martyna
Mengoni, Miriam
Dragolov, Miroslav
Iglesias-Pena, Nicolás
Booken, Nina
Enechukwu, Nkechi Anne
Persa, Oana-Diana
Oninla, Olumayowa Abimbola
Theofilogiannakou, Panagiota
Kage, Paula
Neto, Roque Rafael Oliveira
Peralta, Rosario
Afiouni, Rym
Schuh, Sandra
Schnabl-Scheu, Saskia
Vural, Seçil
Hudson, Sharon
Saa, Sonia Rodriguez
Hartmann, Sören
Damevska, Stefana
Finck, Stefanie
Braun, Stephan Alexander
Hartmann, Tim
Welponer, Tobias
Sotirovski, Tomica
Bondare-Ansberga, Vanda
Ahlgrimm-Siess, Verena
Frings, Verena Gerlinde
Simeonovski, Viktor
Zafirovik, Zorica
Maul, Julia-Tatjana
Lehr, Saskia
Wobser, Marion
Debus, Dirk
Riad, Hassan
Pereira, Manuel P.
Lengyel, Zsuzsanna
Balcere, Alise
Tsakiri, Amalia
Braun, Ralph P.
Brinker, Titus J. http://orcid.org/0000-0002-3620-5919
Article History
Received: 24 March 2023
Accepted: 31 October 2023
First Online: 15 January 2024
Competing interests
: PT reports grants from Lilly, consulting fees from Silverchair, lecture honoraria from Lilly, FotoFinder and Novartis, outside of the present publication. TJB owns a company that develops mobile apps (Smart Health Heidelberg GmbH, Heidelberg, Germany), outside of the scope of the submitted work. WS received travel support for participation in congresses and / or (speaker) honoraria as well as research grants from medi GmbH Bayreuth, Abbvie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, GSK, Janssen, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi Genzyme, and UCB outside of the present publication. MLV received travel support for participation in congresses and / or (speaker) honoraria as well as research grants from Abbvie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, Janssen, Kyowa Kirin, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi Genzyme, and UCB outside of the present publication. BS is on the advisory board or has received honoraria from Immunocore, Almirall, Pfizer, Sanofi, Novartis, Roche, BMS and MSD, research funding from Novartis and Pierre Fabre Pharmaceuticals, and travel support from Novartis, Roche, Bristol-Myers Squibb and Pierre Fabre Pharma, outside the submitted work. SH is on the advisory board or has received honoraria from Novartis, Pierre Fabre, BMS and MSD outside the submitted work. KD has received honoraria from Novartis, Pierre Fabre and Roche outside the submitted work. SF reports consulting or advisory board membership: Bayer, Illumina, Roche; honoraria: Amgen, Eli Lilly, PharmaMar, Roche; research funding: AstraZeneca, Pfizer, PharmaMar, Roche; travel or accommodation expenses: Amgen, Eli Lilly, Illumina, PharmaMar, Roche. JSU is on the advisory board or has received honoraria and travel support from Amgen, Bristol Myers Squibb, GSK, Immunocore, LeoPharma, Merck Sharp and Dohme, Novartis, Pierre Fabre, Roche, Sanofi outside the submitted work ME has received honoraria and travel expenses from Novartis and Immunocore. SHo received travel support for participation in congresses, (speaker) honoraria and research grants from Almirall, UCB, Janssen, Novartis, LEO Pharma and Lilly outside of the present publication. SP has received travel support for participation in congresses and/or speaker honoraria from Abbvie, Lilly, MSD, Novartis, Pfizer and Sanofi outside of the present publication. SPo is on the advisory board or has received honoraria from Galenicum Derma, ISDIN, Cantabria Labs and Mesoestetic. RLB has received support from Castle Bioscience for the International Melanoma Pathology Study Group Symposium and Workshop. MG served as consultant to argenx (honoraria paid to institution) and Almirall and received honoraria for participation in advisory boards / travel support from Biotest, GSK, Janssen, Leo Pharma, Lilly, Novartis and UCB - all outside the scope of the submitted work. MVH received honoraria from MSD, BMS, Roche, Novartis, Sun Pharma, Sanofi, Almirall, Biofrontera, Galderma. The other authors declare no competing interests.